High-frequency microsatellite instability is associated with defective DNA mismatch repair in human melanoma

Ester Alvino1, Giancarlo Marra, Elena Pagani

  • 1Institute of Neurobiology and Molecular Medicine, CNR, Rome, Italy.

Insights

High-frequency microsatellite instability in melanoma is linked to defective DNA mismatch repair, specifically the absence of hMLH1 and hPMS2 proteins. This mirrors findings in other cancers, suggesting a common mechanism for this instability.

Area of Science:

  • Molecular Biology
  • Oncology
  • Genetics

Background:

  • Microsatellite instability (MSI) is observed in various cancers, including colorectal, endometrial, ovarian, and melanoma.
  • In colorectal tumors, high-frequency MSI (MSI-H) correlates with inactivation of DNA mismatch repair (MMR) genes like hMSH2, hMLH1, or hPMS2.
  • The role of MSI and MMR gene expression in melanoma has not been extensively studied.

Purpose of the Study:

  • To investigate the relationship between microsatellite instability and mismatch repair activity in melanoma cell lines and their derived tumors.
  • To analyze the expression of key mismatch repair proteins (hMSH2, hMSH6, hMLH1, hPMS2) in melanoma.

Main Methods:

  • Analysis of microsatellite instability (MSI) in five melanoma cell lines and corresponding tumor specimens.
  • Assay of DNA mismatch repair (MMR) activity in cell line extracts.
  • Western blot analysis to detect the expression of hMSH2, hMSH6, hMLH1, and hPMS2 proteins.

Main Results:

  • Four out of five melanoma cell lines exhibited normal MMR activity and expressed all tested MMR proteins; these displayed no or low-frequency MSI.
  • The fifth cell line lacked hMLH1 and hPMS2 proteins, showed deficient MMR activity, and presented high-frequency MSI (MSI-H).
  • Tumor specimen analysis confirmed these findings, with the tumor lacking hMLH1 and hPMS2 exhibiting MSI-H.

Conclusions:

  • In melanoma, high-frequency microsatellite instability is strongly associated with a defective mismatch repair system, particularly the loss of hMLH1 and hPMS2.
  • This suggests that, similar to epithelial tumors, MSI-H in melanoma is a reliable indicator of MMR deficiency.
  • Further large-scale studies are needed to determine the prevalence of MMR loss in human melanoma.

Related Concept Videos

Mismatch Repair01:36

Mismatch Repair

Overview
Nucleotide Excision Repair01:08

Nucleotide Excision Repair

Overview
Mismatch Repair01:36

Mismatch Repair

Overview
Nucleotide Excision Repair01:38

Nucleotide Excision Repair

DNA Distortion and Damage
Cells are regularly exposed to mutagens—factors in the environment that can damage DNA and generate mutations. UV radiation is one of the most common mutagens and is estimated to introduce a significant number of changes in DNA. These include bends or kinks in the structure, which can block DNA replication or transcription. If these errors are not fixed, the damage can cause mutations, which in turn can result in cancer or disease depending on which sequences are...
Mismatch Repair01:20

Mismatch Repair

Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
Spontaneous and Induced Mutations01:30

Spontaneous and Induced Mutations

Spontaneous mutations arise infrequently during DNA replication due to errors in the process. A key factor behind these errors is tautomeric shifts in nitrogenous bases, where bases transition from keto to enol forms or amino to imino forms. This shift can alter base-pairing rules, leading to mutations. Additionally, reactive oxygen species (ROS) arising from aerobic metabolism can damage DNA, resulting in depurination (loss of a purine base) or depyrimidination (loss of a pyrimidine base).